background

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep

Welcome to Dwaey, specifically on Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep page.
This medicine contains important and useful components, as it consists of
Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep is available in the market in concentration.

Generic Name of Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep - Learn More

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep Precaution - What You Need to Know

The combination of Adenosine 0.2%, Cytochrome C 0.05%, and Nicotinamide eye preparation requires careful use in certain populations and clinical conditions:
- Pregnancy: The safety of this topical eye preparation during pregnancy has not been well established. It is classified as a Category C drug, meaning animal studies may show adverse effects, but there are no sufficient human data. It should only be used during pregnancy if the benefits outweigh the risks.
- Breastfeeding: While there is limited information on the excretion of these ingredients into breast milk, caution should be exercised, and the medication should only be used when absolutely necessary during breastfeeding.
- Eye Conditions: Care should be taken in patients with pre-existing ocular conditions, such as dry eye syndrome or ocular surface disease. Adenosine may have transient effects on intraocular pressure and may not be suitable for patients with conditions like glaucoma.
- Sensitivity or Allergy: If there is a history of hypersensitivity or an allergic reaction to any component of the formulation (adenosine, cytochrome C, or nicotinamide), the drug should be avoided. Sensitivity to preservatives in the eye preparation should also be taken into account.
- Contact Lens Wearers: This eye preparation is generally not recommended for patients who wear contact lenses, unless advised otherwise by a healthcare provider. If used, it should be removed prior to application of the eye preparation, as it may contain preservatives that could irritate the lenses.

Monitoring parameters include observing for any irritation, redness, or discomfort in the eye. Regular monitoring of intraocular pressure should be conducted in patients with a history of glaucoma or ocular hypertension.

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep Indication - Uses and Benefits

This combination eye preparation is primarily indicated for the treatment of ocular surface disorders such as dry eye syndrome, where there is inflammation and oxidative stress on the corneal surface. The specific ingredients have the following roles:
- Adenosine (0.2%): Adenosine has anti-inflammatory and antioxidant properties. It works by modulating cellular energy metabolism and reducing oxidative stress, helping to improve corneal healing and restore the normal function of ocular cells.
- Cytochrome C (0.05%): Cytochrome C plays a role in cellular respiration and acts as an antioxidant. It helps protect against oxidative damage and assists in the repair of cellular damage in the ocular tissues.
- Nicotinamide (0.05%): Nicotinamide, a form of vitamin B3, is known for its anti-inflammatory properties and its role in improving the barrier function of the skin and mucosal tissues. In the eye, it helps reduce inflammation, improves the health of the epithelial cells, and supports tissue repair.
This combination may be used in conditions like dry eyes, corneal damage due to oxidative stress, and other ocular surface disorders, offering a therapeutic benefit for tissue repair and inflammation reduction.

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep Contraindications - Important Warnings

This combination eye preparation is contraindicated in the following conditions:
- Hypersensitivity: Patients with known hypersensitivity to any of the ingredients—adenosine, cytochrome C, or nicotinamide—should avoid use to prevent potential allergic reactions or irritation.
- Active Eye Infections: The product should not be used in patients with active ocular infections, such as bacterial conjunctivitis, as the presence of infection could be exacerbated by the formulation.
- Severe Dry Eye Syndrome: In cases of severe dry eye disease with corneal abrasion or ulceration, the product should be used cautiously under medical supervision. If no improvement is observed or if symptoms worsen, use should be discontinued.
- Glaucoma: Patients with uncontrolled glaucoma or those with a history of elevated intraocular pressure should avoid using this product unless specifically recommended by an ophthalmologist, as it may alter intraocular pressure.

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep Side Effects - What to Expect

The side effects of this eye preparation are typically mild, but some patients may experience:
- Common Side Effects:
- Eye Irritation or Redness: A transient mild irritation or redness may occur immediately after application. This is typically short-lived and resolves after a few minutes.
- Blurred Vision: Temporary blurred vision may be experienced immediately after applying the drops. Patients should avoid activities that require clear vision, such as driving, until their vision clears.
- Dry Eyes: While the formulation is intended to treat dry eye, some users may experience an initial feeling of dryness or discomfort, especially in cases of more severe dry eye disease.
- Less Common Side Effects:
- Allergic Reactions: Although rare, some individuals may experience hypersensitivity reactions, including itching, swelling, or a rash around the eyes. If these symptoms occur, the medication should be discontinued and a healthcare provider should be consulted.
- Stinging or Burning: A mild stinging or burning sensation can occur upon application but is usually brief and should subside quickly.
- Management of Side Effects: In case of persistent discomfort or more severe reactions (e.g., significant irritation or an allergic response), patients should stop using the eye preparation and consult an eye care professional.

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep Pregnancy Category ID - Safety Information

3

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep Mode of Action - How It Works

The mechanism of action of this combination eye preparation is based on the synergistic effects of its three components:
- Adenosine: Acts on the adenosine receptors in ocular cells to reduce inflammation and oxidative stress, promoting cellular energy production and tissue repair. Its antioxidant properties protect the corneal cells from damage caused by free radicals.
- Cytochrome C: This mitochondrial protein plays a vital role in cellular energy metabolism. In the eye, cytochrome C helps protect cells from oxidative damage by neutralizing free radicals, supporting cellular repair, and improving mitochondrial function.
- Nicotinamide: As a precursor to NAD+ (nicotinamide adenine dinucleotide), nicotinamide helps maintain cellular metabolism and improve skin barrier function. In the eye, it helps reduce inflammation, repair epithelial cells, and support overall tissue regeneration, leading to enhanced healing of the ocular surface.

These ingredients work together to reduce oxidative stress, inflammation, and cell damage, improving the overall health and integrity of the eye’s surface tissues. The formulation targets both the healing and protective aspects of ocular surface management, making it effective for treating dry eye and other conditions associated with oxidative damage.

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep Drug Interactions - What to Avoid

While interactions between this combination eye preparation and systemic medications are unlikely, a few key considerations should be kept in mind:
- Topical Medications: The use of other topical eye drops or ointments should be spaced out by at least 5-10 minutes to prevent any potential interactions or interference with the absorption of the ingredients in this formulation.
- Ocular Medications: If the patient is using other medications for eye conditions, such as corticosteroids or other anti-inflammatory agents, these may interact with the active ingredients in the formulation, potentially affecting its efficacy. It is important to consult an ophthalmologist before combining eye therapies.
- Contact Lenses: The use of contact lenses while using the eye preparation is not recommended unless specifically advised by a healthcare provider. The preservative in the eye preparation may interact with the lenses, potentially leading to discomfort or damage to the lens.

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep Adult Dose - Recommended Dosage

For adults, the standard dosage for the combination eye preparation is one drop in the affected eye or eyes twice daily or as prescribed by a healthcare provider. The drops should be administered with caution to avoid contamination of the bottle tip, and patients should avoid touching the tip to their eyes or any surfaces.

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep Child Dose - Dosage for Children

In pediatric patients, the use of this eye preparation should be determined by a healthcare provider. The dosage is generally the same as for adults (one drop in the affected eye twice daily), but it should be used under the supervision of a physician, particularly in young children, as the safety and efficacy of the product in pediatric patients are not fully established. Regular monitoring is recommended for any adverse effects.

Adenosine 0.2% + Cytochrome C 0.05% + Nicotinamide eye prep Renal Dose - Dosage for Kidney Conditions

There are no specific renal dose adjustments recommended for this topical eye preparation, as the components are minimally absorbed systemically. However, patients with severe renal impairment should be monitored closely for any potential systemic effects if other medications are being used concurrently.

  • Drugs for lens opacification -
  • banner

    Report Error

    Please feel welcome to contact us with any price or medical error. Our team will receive any reports.

    Available as

    Not available in a medicine form yet